Joseph R. Hyde III

Description

Mr. Hyde, in conjunction with Dr. Wills’ appointment as our Executive Chairman effective March 2, 2015, was appointed as the Board’s Lead Di...

Joseph R. Hyde III has made 1 investments, with 0 in the past 12 months and 0% as lead.

FAQ

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

North America, Texas, United States, Austin

Co-Investments: 1

North America, Tennessee, United States, Memphis

Co-Investments: 1

Memphis, Tennessee, United States

At GTx, They focus on the development of small molecules that selectively modulate the effects of certain hormones produced by the body.

BiopharmaBiotechnologyHealth Care

Series EAug 20, 2003

Amount Raised: $20,000,000